Drug-delivery tech developer AMW lands $30m from EU bank

Drug-delivery tech developer AMW has landed $30 million from the European Union’s lending institution to help fund the company’s development activities and expand production capacity.

The German pharmaceutical company’s newly-acquired funds will specifically support a new R&D facility located in Bavaria.

Get the full story at our sister site, Drug Delivery Business News.

The post Drug-delivery tech developer AMW lands $30m from EU bank appeared first on MassDevice.